Epigenetic regulation of immune escape genes in cancer Thomas B. TomasiWilliam J. MagnerA. Nazmul H. Khan Review 06 May 2006 Pages: 1159 - 1184
Tumor progression despite massive influx of activated CD8+ T cells in a patient with malignant melanoma ascites Helena HarlinTodd V. KunaThomas F. Gajewski Original Article 09 February 2006 Pages: 1185 - 1197
Telomere length of in vivo expanded CD4+CD25+ regulatory T-cells is preserved in cancer patients Dominik WolfHolger RumpoldAnna M. Wolf Original Article 16 December 2005 Pages: 1198 - 1208
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells Joseph W. FayA. Karolina PaluckaJacques Banchereau Original Article 06 December 2005 Pages: 1209 - 1218
Characterization of IL-2-activated TILs and their use in intrapericardial immunotherapy in malignant pericardial effusion Uhi TohTeruhiko FujiiHideaki Yamana Original Article 16 December 2005 Pages: 1219 - 1227
IL-4 inhibits the TNF-α induced proliferation of renal cell carcinoma (RCC) and cooperates with TNF-α to induce apoptotic and cytokine responses by RCC: implications for antitumor immune responses Claudia FalkensammerKarin JöhrerMartin Thurnher Original Article 28 January 2006 Pages: 1228 - 1237
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells Shari Pilon-ThomasMonique VerhaegenJames J Mulé Original Article 29 November 2005 Pages: 1238 - 1246
The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients Margarita SkopelitiIoannis F. VoutsasOurania E. Tsitsilonis Original Article 02 February 2006 Pages: 1247 - 1257
Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses Yunfei GaoDongqing ZhangZhinan Yin Original Article 16 December 2005 Pages: 1258 - 1266
Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model Zhengrong CuiFu Qiu Original Article 16 December 2005 Pages: 1267 - 1279
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique Anette KnudsenSissel E. MonstadChristian A. Vedeler Original Article 21 January 2006 Pages: 1280 - 1284
The anti-tumor efficacy of a GM-CSF-secreting tumor cell vaccine is not inhibited by docetaxel administration Rodney A. PrellLisa GearinKarin Jooss Original Article 12 January 2006 Pages: 1285 - 1293
Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin Marion WobserPetra KeikavoussiJuergen C. Becker Short Communication 29 November 2005 Pages: 1294 - 1298